Exelixis
Stock Forecast, Prediction & Price Target
Exelixis (EXEL) stock Price Target by analysts
$31.18
Potential downside: -16.94%
Exelixis price prediction
What is Exelixis stock analysts` prediction?
Exelixis stock forecast: Based on 11 Wall Street analysts` predicted price targets for Exelixis in the last 3 months, the avarage price target is $31.18, with a high forecast of $NaN. The average price target represents a -16.94% change from the last price of $37.54.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Exelixis stock Price Target by analysts
Full breakdown of analysts given Exelixis price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Joseph Catanzaro Piper Sandler | 0% 0/1 | 10 months ago | $36 -4.10% downside | $28.73 | TheFly | Previous targets (0) |
Asthika Goonewardene Truist Financial | 0% 0/2 | 10 months ago | $38 1.22% upside | $28.73 | TheFly | Previous targets (1) |
Etzer Darout BMO Capital | 0% 0/1 | 10 months ago | $36 -4.10% downside | $32.56 | StreetInsider | Previous targets (0) |
David Lebowitz Citigroup | 0% 0/2 | 10 months ago | $38 1.22% upside | $28.73 | StreetInsider | Previous targets (1) |
Chris Shibutani Goldman Sachs | 50% 1/2 | 11 months ago | $18 -52.05% downside | $28.5 | StreetInsider | Previous targets (1) |
Christopher Liu Leerink Partners | 0% 0/1 | 11 months ago | $28.5 -24.08% downside | $28.5 | StreetInsider | Previous targets (0) |
Kennen MacKay RBC Capital | 0% 0/1 | 11 months ago | $34 -9.42% downside | $28.5 | StreetInsider | Previous targets (0) |
Akash Tewari Jefferies | 0% 0/1 | 11 months ago | $33 -12.09% downside | $28.8 | TheFly | Previous targets (0) |
Jeffrey Hung Morgan Stanley | 0% 0/3 | 11 months ago | $30 -20.08% downside | $28.5 | StreetInsider | Previous targets (2) |
Sudan Loganathan Stephens | 0% 0/1 | 11 months ago | $23 -38.73% downside | $26.24 | StreetInsider | Previous targets (0) |
Asthika Goonewardene Truist Financial | 0% 0/2 | 11 months ago | $33 -12.09% downside | $26.24 | StreetInsider | Previous targets (1) |
Jeffrey Hung Morgan Stanley | 0% 0/3 | 11 months ago | $28 -25.41% downside | $25.97 | TheFly | Previous targets (2) |
Ashwani Verma UBS | 0% 0/1 | 12 months ago | $30 -20.08% downside | $26.82 | TheFly | Previous targets (0) |
David Lebowitz Citigroup | 0% 0/2 | 12 months ago | $31 -17.42% downside | $26.46 | StreetInsider | Previous targets (1) |
Jason Gerberry Bank of America Securities | 0% 0/1 | about 1 year ago | $30 -20.08% downside | $25.44 | StreetInsider | Previous targets (0) |
Robert Burns H.C. Wainwright | 0% 0/1 | about 1 year ago | $29 -22.74% downside | $26.52 | StreetInsider | Previous targets (0) |
Silvan Tuerkcan JMP Securities | 0% 0/1 | about 1 year ago | $29 -22.74% downside | $23.45 | TheFly | Previous targets (0) |
David Lebowitz New Street | 0% 0/1 | over 1 year ago | $31 -17.42% downside | $21.06 | StreetInsider | Previous targets (0) |
George Farmertzer Darout BMO Capital | 0% 0/1 | over 1 year ago | $29 -22.74% downside | $21.07 | StreetInsider | Previous targets (0) |
Peter Lawson Barclays | 0% 0/1 | over 1 year ago | $25 -33.40% downside | $23.68 | StreetInsider | Previous targets (0) |
Unknown JMP Securities | N/A | over 2 years ago | $25 -33.40% downside | $16.52 | Benzinga | N/A |
Michael Schmidt Guggenheim | 0% 0/1 | about 4 years ago | $30 -20.08% downside | $18.02 | StreetInsider | Previous targets (0) |
Chris Shibutani Goldman Sachs | 50% 1/2 | over 4 years ago | $23 -38.73% downside | $24.34 | TheFly | Previous targets (1) |
Jeffrey Hung Morgan Stanley | 0% 0/3 | over 4 years ago | $26 -30.74% downside | $23.74 | TipRanks | Previous targets (2) |
Exelixis Financial Estimates
Exelixis Revenue Estimates
Exelixis EBITDA Estimates
Exelixis Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/30/2022 | 12/29/2023 | 12/29/2025 | 12/30/2025 | 12/29/2026 | 12/29/2027 |
Revenue
% change YoY
| $1.43B N/A | $1.61B 12.27% | $1.83B 13.60% | Avg: $2.06B Low: $1.86B High: $2.22B avg. 12.63% | Avg: $2.30B Low: $2.07B High: $2.42B avg. 11.84% | Avg: $2.27B Low: $2.12B High: $2.42B avg. -1.17% | Avg: $2.62B Low: $2.45B High: $2.79B avg. 15.29% |
Net Income
% change YoY
| $231.06M N/A | $182.28M -21.11% | $207.76M 13.97% | Avg: $444.35M Low: $337.53M High: $623.64M avg. 113.87% | Avg: $387.27M Low: $236.92M High: $529.02M avg. -12.84% | Avg: $570.95M Low: $398.61M High: $916.17M avg. 47.43% | Avg: $739.76M Low: $676.37M High: $800.57M avg. 29.56% |
EBITDA
% change YoY
| $286.66M N/A | $201.48M -29.71% | $196.60M -2.42% | Avg: $381.56M Low: $345.04M High: $412.59M avg. 94.07% | Avg: $621.37M Low: $559.46M High: $653.93M avg. 62.84% | Avg: $421.71M Low: $393.91M High: $448.38M avg. -32.13% | Avg: $486.22M Low: $454.17M High: $516.96M avg. 15.29% |
EPS
% change YoY
| $0.73 N/A | $0.57 -21.91% | $0.65 14.03% | Avg: $1.47 Low: $1.05 High: $1.94 avg. 125.41% | Avg: $1.24 Low: $0.73 High: $1.63 avg. -15.68% | Avg: $1.88 Low: $1.24 High: $2.85 avg. 52.30% | Avg: $2.3 Low: $2.1 High: $2.49 avg. 22.30% |
Operating Expenses
% change YoY
| $1.09B N/A | $1.35B 23.39% | $1.58B 17.39% | Avg: $575.06M Low: $520.03M High: $621.83M avg. -63.75% | Avg: $617.88M Low: $556.32M High: $650.26M avg. 7.44% | Avg: $635.57M Low: $593.68M High: $675.76M avg. 2.86% | Avg: $732.80M Low: $684.49M High: $779.13M avg. 15.29% |
FAQ
What is Exelixis stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 44.50% in 2025-2027.
We have gathered data from 13 analysts. Their low estimate is 337.53M, average is 444.35M and high is 623.64M.
What is Exelixis stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.64% in 2025-2027.
We have gathered data from 16 analysts. Their low revenue estimate is $1.86B, average is $2.06B and high is $2.22B.
What is Exelixis stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 46.08% in 2025-2027.
We have gathered data from 13 analysts. Their low earnings per share estimate is $1.05, average is $1.47 and high is $1.94.
What is the best performing analyst?
In the last twelve months 11 analysts have been covering Exelixis stock. The most successful analyst is Joseph Catanzaro.